Macquarie Group’s Delcath Systems DCTH Stock Holding History

Macquarie Group’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,393	Closed	-$25.7K	–	1025
2025 Q3	$25.7K	Buy	+2,393	New	+$26.7K	﹤0.01%	1547

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Macquarie Group's DCTH Position: Q4 2025 in Review

Macquarie Group sold out of Delcath Systems (DCTH) in Q4 2025, closing a stake of 2,393 shares — an estimated $25.7K sold.

Macquarie Group first reported a position in DCTH in Q3 2025 and held it in 1 quarter. The position peaked at $25.7K in Q3 2025. 119 funds tracked by Wall St. Rank hold DCTH as of Q4 2025.

Macquarie Group reported no remaining Delcath Systems position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 2,393 Delcath Systems shares in Q4 2025, an estimated $25.7K.
Macquarie Group first reported a position in Delcath Systems in Q3 2025 and held it in 1 quarter.
Macquarie Group's Delcath Systems position peaked at $25.7K in Q3 2025.
119 funds tracked by Wall St. Rank held Delcath Systems as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.